What is Span-America Medical Systems Total Inventories?
Span-America Medical Systems's total inventories for the quarter that ended in Mar. 2017 was $7.37 Mil. Span-America Medical Systems's average total inventories from the quarter that ended in Dec. 2016 to the quarter that ended in Mar. 2017 was $7.27 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Span-America Medical Systems's Net-Net Working Capital per share for the quarter that ended in Mar. 2017 was $4.10.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Span-America Medical Systems's Days Inventory for the
three
months ended in Mar. 2017 was 70.85.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Span-America Medical Systems's Inventory Turnover for the quarter that ended in Mar. 2017 was 1.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Span-America Medical Systems's Inventory-to-Revenue for the quarter that ended in Mar. 2017 was 0.48.
Span-America Medical Systems Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Span-America Medical Systems Total Inventories Chart
Span-America Medical Systems Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Span-America Medical Systems (NAS:SPAN) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Span-America Medical Systems's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2017 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Span-America Medical Systems's Inventory to Revenue for the quarter that ended in Mar. 2017 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Span-America Medical Systems Total Inventories Related Terms
Thank you for viewing the detailed overview of Span-America Medical Systems's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Span-America Medical Systems (Span-America Medical Systems) Business Description
Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SPAN has been successfully added to your 